Abcam plc a global leader in the supply of life science research tools, announces the appointment of Tommy Thomas as Vice President of Investor Relations.
Latest Fintech News: Parallel Finance Continues Rapid Product Expansion With Launch of Omni: NFT Money Market
Tommy, who will be based in our Waltham, MA office, has over 20 years’ experience in the life sciences sector, largely focused in the area of research tools. He joins Abcam from Avantor, where he was Vice President, Investor Relations for several years. Prior to this he was Vice President of Investor Relations, and then Chief Financial Officer of Global Services at Perkin Elmer. Before joining Perkin Elmer, Tommy spent eight years as a buy side analyst for TIAA-CREF focused on the medical technology & life science tools areas.
Latest Fintech News: Earned Wage Access Platform Tapcheck Raises $20 Million Series A
Michael Baldock, Chief Financial Officer of Abcam, said: “I am delighted to have Tommy joining us. His deep industry experience, significant investor relations expertise, and strong institutional investor and research analyst relationships are a major step forward for us. Tommy will be a real asset to Abcam and our investors as we continue to grow, differentiate ourselves in the marketplace, and deliver value for all our stakeholders.”
Tommy Thomas commented: “I am very pleased to join Abcam at this important time in its evolution. The Company’s customer-centric model focusing on new product innovation for researchers and clinicians in the life sciences industry is highly differentiated. I look forward to learning and telling our story as I build new friendships along the way.”
Latest Fintech News: Dalrada Financial Corporation Appoints Professor Elizabeth Winzeler to Healthcare Advisory Board
[To share your insights with us, please write to sghosh@martechseries.com]
